IDEAYA Biosciences Inc.
IDEAYA is a synthetic lethality focused precision medicine oncology company developments and discovery of targeted therapeutics for patient populations selected using molecular diagnostics. The headquarters is in USA.
IDEAYA Annual Total Revenue for year ending Dec-2022 was 50 million USD and and Net loss for year ending Dec-2022 was -58 million USD.
IDEAYA Annual Total Revenue for year ending Dec-2021 was 27 million USD and and Net loss for year ending Dec-2021 was -50 million USD.
As on 2022, IDEAYA has 103 employees.